Advene Health
image (704) 844-0181

Brixadi Medication Treatment

Contact Us
image (704) 844-0181
Brixadi Medication Treatment

Long-Acting Brixadi Treatment for Opioid Use Disorder in Charlotte

Brixadi is an extended-release buprenorphine injection used to treat opioid use disorder. At Advene Health, we offer Brixadi as part of our comprehensive Medication-Assisted Treatment program, providing patients with a structured and flexible long-acting option.

Brixadi is available in both weekly and monthly formulations, allowing for individualized treatment planning based on clinical needs and recovery goals.

Contact Us
image (704) 844-0181

Understanding Your Treatment

What Is Brixadi?

Brixadi is an FDA-approved injectable form of buprenorphine designed to deliver steady medication levels over time. It works by partially activating opioid receptors in a controlled way, reducing cravings and withdrawal symptoms without producing the euphoric effects of full opioids.
Because Brixadi is administered by a medical professional, it:

Provides consistent medication delivery

Reduces the need for daily dosing

Lowers risk of missed doses

Decreases misuse potential

Supports improved treatment adherence

How Brixadi Treatment Works at Advene Health

At Advene Health, treatment with Brixadi begins with a comprehensive clinical evaluation to determine whether this medication-assisted treatment option is appropriate for each patient’s individual needs.

Our clinical evaluation process may include

Once approved for treatment, Brixadi injections are administered in-office with ongoing medical monitoring and integrated behavioral health support to promote stabilization and recovery.
  • image ASAM Criteria assessment
  • image Biopsychosocial evaluation
  • image DSM-5 diagnostic review
  • image Substance use history analysis

Our treatment program may include

This coordinated treatment approach supports stabilization while strengthening long-term recovery outcomes.
  • image Medication management
  • image Individual therapy
  • image Trauma-informed care
  • image Relapse prevention planning
  • image Ongoing progress evaluation
Weekly and Monthly Treatment Options
One of the advantages of Brixadi is its flexible dosing schedule.
Treatment decisions are based on comprehensive clinical assessment and individualized planning.

Buprenorphine may be appropriate for individuals who:

Weekly Brixadi may be appropriate for patients who need closer monitoring during early recovery.

Monthly Brixadi provides extended stabilization for individuals who are clinically stable and seeking longer-term structure.

Insurance Coverage for Brixadi

Insurance Coverage for Brixadi

Advene Health accepts Medicaid, Medicare, Blue Cross Blue Shield, Cigna, Aetna, United Healthcare, and Tricare. For eligible patients, Brixadi may be covered under Medicaid and other insurance plans.

Our admissions team verifies benefits and explains coverage before treatment begins.